Policyctic ovary syndrome. Sclerocystic ovary syndrome Stein-Leventhal syndrome
Conditions
Interventions
Intervention 1: The experimental group will receive salvia officinalis alcoholic extract 150 mg capsules twice a day orally for 8 weeks . Intervention 2: The control group will take similar capsules w
Treatment - Drugs
Placebo
The experimental group will receive salvia officinalis alcoholic extract 150 mg capsules twice a day orally for 8 weeks .
The control group will take similar capsules with starch as a placebo twice a day for 8 weeks
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1-The samples should have the desire to participate in the study and informed consent was taken from them. 2- They should have Iranian nationality. 3- Don’t use food and drug supplements such as vitamins, minerals... 4- They shouldn't be on a special diet such as Low-sugar, low-fat or vegetarian diets. 5- Absence of known mental illness or chronic physical disease according to the information given from the patient. 6- They shouldn't be pregnant and has no desire to become pregnant during the study. 7- The participant and her wife, shouldn't be addicted to drugs and also shouldn't take any tranquilizers or psychotropic substances. 8 -Hormonal drugs (except oral contraceptive compounds), reducing or increasing the weight compounds, the blood lipid lowering drugs, the blood glucose lowering drugs and Anti-epileptic drugs should not have been used during the study and two months before it. 9- They are not undergoing infertility treatment. 10- They should not have been under the influence of stressful events during the last three months. Exclusion criteria: 1- Participants withdrew from participating in the study at any part of study. 2- In case of intolerable or harmful side effects, such as severe nausea and vomiting or allergy caused by the salvia officinalis capsules.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wheight. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Weight in kilograms.;Waist circumference. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Centimetre.;Hip circumference. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Centimetre.;Body Mass Index ( BMI ). Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Is defined as the body mass divided by the square of the body height, and is universally expressed in units of kg/m2.;Systolic and diastolic blood pressure. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Will be measured with Sphygmomanomete in millimeters of mercury (mm Hg).;Fasting Blood Sugar ( FBS ). Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Venous blood samples will be collected and then enzymatic colorimetricd methode using special kits and autoanalyzer will be measured in milligrams per deciliter.;Triglyceride. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Venous blood samples will be collected and then enzymatic colorimetricd methode using special kits and autoanalyzer will be measured in milligrams per deciliter.;Cholestrol. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Venous blood samples will be collected and then enzymatic colorimetricd methode using special kits and autoanalyzer will be measured in milligrams per deciliter.;Low density lipoprotein cholesterol (LDL). Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Venous blood samples will be collected and then enzymatic colorimetricd methode using special kits and autoanalyzer will be measured in milligrams per deciliter.;High density lipoprotein cholesterol (HDL). Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactArezoo Malaki hajiagha
Iran University of Medical Sciences, School of Nrsing and Midwifery
Outcome results
None listed